Steve McPhail has been named the new CEO of Expression Analysis, a microarray analysis firm, the Durham, NC, company said last week. He replaces Donald Holzworth, president and CEO of Analytical Sciences, who has acted as EA’s interim CEO since Sept. 2001 when ASI began incubating the company. Holzworth will now serve as chairman of EA’s board of directors.
Michael Minas has been appointed an interim member of MWG Biotech’s internal management board, and will serve on the board until May 21st, the company said this week. Minas has been head of MWG Biotech’s accounting and financial division since September 2001. He will serve with Thomas Becker, chairman of the board of management.
Robert Rosenthal, president and COO of Boston Life Sciences, has been named to the board of directors for Protedyne, a lab automation supplier for genomics, proteomics, and biopharmaceutical research, the company announced.
Jim Lindelien, founder and CTO of TimeLogic, is leaving the company “to pursue new opportunities,” the company said Feb. 27. Lindelien, who engineered the company’s bioinformatics solution DeCypher, will not be directly replaced, but Roland Luethy, the company’s senior bioinformatics research scientist, will head up future development of the DeCypher system, according to TimeLogic.
Peter Ehrenheim, who has directed Amersham Biosciences’ protein separations business as a vice president under president Andrew Carr, has been named president of protein separations, a new position, reporting to William Castell, the CEO of Amersham PLC, the company said last week.